NADPH
Based on 20 publication(s) in Google Scholar
NADPH is a coenzyme of glutathione reductase (GR), thioredoxin reductase (TrxR) and NADPH oxidase (NOX), and participates in redox reactions as a hydrogen donor. NADPH has the characteristic of selectively participating in the regulation of cellular redox homeostasis. NADPH exerts antioxidant activity and resists reactive oxygen species (ROS) damage by providing reducing equivalents for the regeneration of glutathione (GSH) and thioredoxin (Trx); at the same time, it acts as a substrate of NOX to generate superoxide anions, mediating oxidative stress and immune response. NADPH participates in maintaining the intracellular reducing environment, biosynthesis and regulating gene expression (such as the Nrf2 pathway), and is mainly used in the study of oxidative stress-related diseases (such as cardiovascular diseases, neurodegenerative diseases, cancer) and immune regulation mechanisms.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.75%
- No. CAS: 53-57-6
- Fòrmula: C21H30N7O17P3
- Peso molecular:745.42
-
Almacenamiento:
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications Citing Use of MedChemExpress (MCE) NADPH
More- Adv Sci (Weinh). 2025 Sep 15:e07283. [Abstract]
- Sci Adv. 2025 Dec 19;11(51):eady2104. [Abstract]
- Mol Ther Oncol. 2024 Sep 17;32(4):200878. [Abstract]
- J Med Chem. 2025 Dec 25;68(24):26383-26404. [Abstract]
- Pharmaceutics. 2026 Jun 10;18(6):718. [Abstract]
- Cell Rep Phys Sci. 2025 Mar 19.
- J Agric Food Chem. 2024 Sep 11;72(36):20064-20076. [Abstract]
- Drug Des Devel Ther. 2020 Nov 30;14:5259-5273. [Abstract]
- Chem Biol Interact. 2022 Dec 1:368:110222. [Abstract]
- Eur J Pharm Sci. 2021 Sep 1:164:105889. [Abstract]
- Mol Plant Pathol. 2025 Dec;26(12):e70196. [Abstract]
- J Mol Struct. 2026 Mar 10.
- iScience. 2024 Aug 30;27(9):110834. [Abstract]
- Microbiol Spectr. 2023 Sep 21;11(5):e0267123. [Abstract]
- JID Innov. 2023 Nov 28;4(2):100251. [Abstract]
- Vet Parasitol. 2026 May:344:110769. [Abstract]
- Xenobiotica. 2022 Feb;52(2):165-176. [Abstract]
- Res Sq. 2026 Jan 12.
- Chemrxiv. 2025 Aug 28.
- Research Square Preprint. 2023 Jul 31.
-
Cell Imaging/Staining
-
WB
-
Cell Imaging/Staining
-
Bio/Physico-chemical Assay
-
Cell Proliferation/Viability Assay
Ver todos los productos específicos de isoformas Endogenous Metabolite
More
Actividad biológica
|
Human Endogenous Metabolite |
In NADK-overexpressing cells, a 4-5-fold increase in NADK concentration increases the survival rate of HEK293 cells after treatment with 1 mM H2O2 and 0.1 mM Menadione (HY-B0332) (treatment for 24 h)[2].
The mRNA and protein expressions of PRDX5 and Nrf2 are also decreased in NADK-overexpressing HEK293 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEK293 cells (control, NADK overexpressing NADK+, NADK knockdown NADK-)
-
Concentration:Intracellular NADPH increased 4-5-fold in NADK(+) cells
-
Incubation Time:
-
Result:Decreased by ~70% in NADK- cells (compared to control) 30 min treatment with 1 mM H2O2 or 100 μM Menadione, followed by 24 h recovery Showed significantly higher viability (10-20% increase) than control cells after H2O2 or Menadione treatment, while NADK- cells exhibited a slight decrease (10%) in viability compared to contro.
Chemical Information
-
No. CAS 53-57-6
-
Appearance Solid
-
Peso molecular 745.42
-
Fòrmula C21H30N7O17P3
-
Color White to light yellow
-
SMILES
O=P(O)(O)O[C@H]1[C@H](N2C3=NC=NC(N)=C3N=C2)O[C@@H]([C@H]1O)COP(OP(OC[C@H]4O[C@@H](N5C=C(CC=C5)C(N)=O)[C@@H]([C@@H]4O)O)(O)=O)(O)=O
-
Structure Classification
-
Initial Source
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Publications (20)
-
Journal Impact Factor
-
Most Recent
-
Adv Sci (Weinh)
Redox Cascade in Chicken Skeletal Muscle: SELENOT Suppression in Selenium Deficiency Triggers Disulfidptosis via mtROS-NADPH Dysregulation. [Abstract]2025 Sep 15:e07283. PMID: 40953299
NADPH purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Sep 15:e07283. [Abstract]
A normal cellular state was recovered by adding TEMPO or NADPH (1mM, 24h), or SLC7A11 knockdown.
NADPH purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Sep 15:e07283. [Abstract]
Western Blot analysis of RAC/WAVE pathway-related indicators in vitro skeletal muscle cells. Muscle cells treated with different condition NADPH(1mM, 24h).
NADPH purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Sep 15:e07283. [Abstract]
mtROS fluorescence staining of skeletal muscle cells in vitro. Muscle cells treated with different condition NADPH(1mM, 24h).
-
Sci Adv
Direct recruitment of TONSOKU by the N-terminal tails of histone variants H2A.X and H2A.W coordinates DNA repair. [Abstract]2025 Dec 19;11(51):eady2104. PMID: 41406205 -
Mol Ther Oncol
AVL-armed oncolytic vaccinia virus promotes viral replication and boosts antitumor immunity via increasing ROS levels in pancreatic cancer. [Abstract]2024 Sep 17;32(4):200878. PMID: 39431173
NADPH purchased from MedChemExpress. Usage Cited in: Mol Ther Oncol. 2024 Sep 17;32(4):200878. [Abstract]
Apoptosis proportion of oncoVV-AVL-treated AsPC-1(Up) and PANC-1 (Down) cells treated with NADPH (300 μM) or NADH. Data are presented as the mean ± SD (n=3).
NADPH purchased from MedChemExpress. Usage Cited in: Mol Ther Oncol. 2024 Sep 17;32(4):200878. [Abstract]
Western blotting detection of the expressions of caspase-3 and caspase-9 in oncoVV or oncoVV-AVL-treated AsPC-1(Up) and PANC-1 (Down) cells treated with NADPH (300 μM).
-
J Med Chem
Discovery of Novel Bifunctional Agents as Potent TRK Inhibitors and Degraders against xDFG Mutation Resistance. [Abstract]2025 Dec 25;68(24):26383-26404. PMID: 41345987 -
Pharmaceutics
CYP3A-Mediated Metabolism of Zastaprazan in Humans and Associated Drug-Drug Interactions. [Abstract]2026 Jun 10;18(6):718. PMID: 42357334 -
-
J Agric Food Chem
2024 Sep 11;72(36):20064-20076. PMID: 39196852 -
Drug Des Devel Ther
Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach. [Abstract]2020 Nov 30;14:5259-5273. PMID: 33299299 -
Chem Biol Interact
Discovery and characterization of the flavonoids in Cortex Mori Radicis as naturally occurring inhibitors against intestinal nitroreductases. [Abstract]2022 Dec 1:368:110222. PMID: 36244406 -
Eur J Pharm Sci
Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors. [Abstract]2021 Sep 1:164:105889. PMID: 34044117 -
Mol Plant Pathol
Negative Immune Regulator CAD7 Functions as a Small-Molecule Aldehyde Reductase and Increases Histamine Accumulation in Arabidopsis. [Abstract]2025 Dec;26(12):e70196. PMID: 41456913
NADPH purchased from MedChemExpress. Usage Cited in: Mol Plant Pathol. 2025 Dec;26(12):e70196. [Abstract]
Enzymatic activities of AtCAD7, AtCAD5, EcYahK, and EcYjgB toward (Z)‐3‐hexenal, acrolein, isovaleraldehyde, salicylaldehyde, and p‐coumaryl aldehyde. No Substrate was negative control. Assays were conducted under standardised conditions (30°C, pH 6.5, 100 μM substrate, 200 μM NADPH).
-
-
iScience
2024 Aug 30;27(9):110834. PMID: 39310768 -
Microbiol Spectr
Potential quorum-sensing inhibitor of Hafnia alvei H4-theaflavin-3,3´-digallate analyzed by virtual screening and molecular simulation. [Abstract]2023 Sep 21;11(5):e0267123. PMID: 37732782 -
JID Innov
ATI-1777, a Topical Jak1/3 Inhibitor, May Benefit Atopic Dermatitis without Systemic Drug Exposure: Results from Preclinical Development and Phase 2a Randomized Control Study ATI-1777-AD-201. [Abstract]2023 Nov 28;4(2):100251. PMID: 38299059 -
Vet Parasitol
2026 May:344:110769. PMID: 41967379 -
Xenobiotica
Metabolites identification and species comparison of Oroxylin A, an anti-cancer flavonoid, in vitro and in vivo by HPLC-Q-TOF-MS/MS. [Abstract]2022 Feb;52(2):165-176. PMID: 35345974 -
-
-
Solvente y solubilidad
H2O : 116.67 mg/mL (156.52 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureza y Documentación
-
Ficha de datos (284 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 1.3415 mL | 6.7076 mL | 13.4153 mL | 33.5381 mL |
| 5 mM | 0.2683 mL | 1.3415 mL | 2.6831 mL | 6.7076 mL | |
| 10 mM | 0.1342 mL | 0.6708 mL | 1.3415 mL | 3.3538 mL | |
| 15 mM | 0.0894 mL | 0.4472 mL | 0.8944 mL | 2.2359 mL | |
| 20 mM | 0.0671 mL | 0.3354 mL | 0.6708 mL | 1.6769 mL | |
| 25 mM | 0.0537 mL | 0.2683 mL | 0.5366 mL | 1.3415 mL | |
| 30 mM | 0.0447 mL | 0.2236 mL | 0.4472 mL | 1.1179 mL | |
| 40 mM | 0.0335 mL | 0.1677 mL | 0.3354 mL | 0.8385 mL | |
| 50 mM | 0.0268 mL | 0.1342 mL | 0.2683 mL | 0.6708 mL | |
| 60 mM | 0.0224 mL | 0.1118 mL | 0.2236 mL | 0.5590 mL | |
| 80 mM | 0.0168 mL | 0.0838 mL | 0.1677 mL | 0.4192 mL | |
| 100 mM | 0.0134 mL | 0.0671 mL | 0.1342 mL | 0.3354 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.